Roka Bioscience (ROKA) Reaches $2.46 1 Year Low; 0 Analysts Are Bullish Countrywide PLC (LON:CWD) Last Week

June 19, 2017 - By Marguerite Chambers

The stock of Roka Bioscience Inc (NASDAQ:ROKA) hit a new 52-week low and has $2.36 target or 4.00% below today’s $2.46 share price. The 9 months bearish chart indicates high risk for the $12.10 million company. The 1-year low was reported on Jun, 19 by Barchart.com. If the $2.36 price target is reached, the company will be worth $484,000 less. About 10,178 shares traded. Roka Bioscience Inc (NASDAQ:ROKA) has declined 50.49% since June 19, 2016 and is downtrending. It has underperformed by 67.19% the S&P500.

Among 10 analysts covering Countrywide Plc (LON:CWD), 0 have Buy rating, 3 Sell and 7 Hold. Therefore 0 are positive. Countrywide Plc had 38 analyst reports since July 30, 2015 according to SRatingsIntel. Jefferies maintained Countrywide PLC (LON:CWD) on Tuesday, November 1 with “Hold” rating. The rating was maintained by Credit Suisse with “Neutral” on Thursday, November 5. The firm earned “Buy” rating on Tuesday, June 7 by Jefferies. The stock of Countrywide PLC (LON:CWD) earned “Neutral” rating by UBS on Friday, November 6. The firm has “Equal Weight” rating given on Friday, March 11 by Barclays Capital. The firm earned “Hold” rating on Thursday, November 24 by Peel Hunt. The rating was maintained by Barclays Capital on Thursday, January 19 with “Equal Weight”. Peel Hunt maintained the shares of CWD in report on Thursday, February 25 with “Hold” rating. Numis Securities downgraded Countrywide PLC (LON:CWD) rating on Thursday, July 30. Numis Securities has “Hold” rating and GBX 522 target. The firm has “Reduce” rating by Peel Hunt given on Thursday, March 9. See Countrywide PLC (LON:CWD) latest ratings:

26/04/2017 Broker: Peel Hunt Rating: Reduce Old Target: GBX 165.00 New Target: GBX 165.00 Maintain
15/03/2017 Broker: UBS Rating: Sell Old Target: GBX 175.00 New Target: GBX 150.00 DownGrade
10/03/2017 Broker: Numis Securities Rating: Hold Old Target: GBX 175.00 New Target: GBX 175.00 Maintain
09/03/2017 Broker: Peel Hunt Rating: Reduce Old Target: GBX 165.00 New Target: GBX 165.00 Maintain
19/01/2017 Broker: Barclays Capital Rating: Equal Weight Old Target: GBX 250.00 New Target: GBX 173.00 Maintain
18/01/2017 Broker: Citigroup Rating: Neutral New Target: GBX 185.00 Maintain
09/01/2017 Broker: Peel Hunt Rating: Reduce Old Target: GBX 170.00 New Target: GBX 165.00 Downgrade

The stock increased 0.48% or GBX 0.75 on June 19, reaching GBX 157. About 410,330 shares traded. Countrywide PLC (LON:CWD) has 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Countrywide plc is an integrated, full service residential estate agency and property services firm in the United Kingdom. The company has market cap of 373.55 million GBP. The Firm offers estate agency and lettings services, together with a range of complementary services, and has a presence in areas and property types which are promoted through locally respected brands. It has a 19.71 P/E ratio. The Firm operates through four divisions: Retail, London, Financial Services and Business to Business .

Roka Bioscience, Inc. is a molecular diagnostics company. The company has market cap of $12.10 million. The Firm is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. It currently has negative earnings. The Firm offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: